Delivery Order SPE2DR25D9762-SPE2DR26FHYP5
- Not listed
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Lidocaine 5% Patch 30s with a ceiling value of $5,062.40 under a firm fixed-price arrangement. This delivery order, awarded on November 27, 2025, with an ultimate completion date of November 28, 2025, was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $6,074.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30s. This firm fixed-price delivery order was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the contractor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS...
- The Defense Logistics Agency awarded a delivery order valued at $3,164.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30s. The award, made on August 21, 2025, with an ultimate completion date of August 22, 2025, was issued under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch in quantities of 30 units. The contract is valued at $4,303.04 with a firm fixed-price structure and is scheduled for completion by August 26, 2025. This delivery order was issued without a set-aside designation, and the place of performance is Park Ridge, Illinois. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,481 to DMS Pharmaceutical Group Inc. for 30 units of Lidocaine 5% Patch on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, serves as the prime contractor on this order. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,055.88 to DMS Pharmaceutical Group Inc. for 30 units of Lidocaine 5% Patch on July 24, 2025. This firm fixed-price delivery order, which is set to be completed by July 25, 2025, will be performed at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to supply this topical anesthetic product to support federal healthcare needs. This...
- The Defense Logistics Agency awarded a $2,183.16 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30s. This delivery order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, carries no set-aside designation and represents a standard procurement vehicle under DLA's pharmaceutical supply operations. The award leverages DMS...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,932.89 to DMS Pharmaceutical Group Inc. for Lidocaine 5% Patch 30s, with an ultimate completion date of October 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The delivery order will be performed in...
- The Defense Logistics Agency awarded a delivery order valued at $7,733.94 to DMS Pharmaceutical Group Inc. for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania. This delivery order...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,673.22 by the Defense Logistics Agency (DLA) on September 17, 2025. The delivery order, which carries a contract number 4569492043, calls for the supply of Lidocaine 5% Patch in quantities of 30 units, with an ultimate completion date of September 18, 2025. The place of performance is listed as Conshohocken,...
- SPE2DR25D9762Indefinite Delivery Contract
- SPE2DR25D9762-SPE2DR26FHYP5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,796.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30S. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 15, 2025, and no set-aside designation was utilized. Performance will take place in Park Ridge, Illinois, with funding provided by the Defense Logistics Agency. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR and valued at $499,999,999 through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy establishing multiple regional prime vendor contractors to supply pharmaceuticals, biologics, and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability as a critical pharmaceutical supplier supporting military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 12/14/25 |